Our approach involved gaining insight into the role of CRIPTO signaling in castration-resistant Nkx3.1-expressing cells (CARNs), targets for oncogenic transformation in prostate cancer (PCa), by integrating the existing Criptoflox/flox into CARNs model. The gene discussed is CRIPTO; the disease is Familial prostate cancer.